Abstract

To evaluate the efficacy and safety of dienogest treatment in patients who had received dienogest for 6 months or more to treat endometriosis with also side effects. Methods-We evaluate the clinical data of 50 women of reproductive age group with endometriosis who had been treated with 2 mg of dienogest once a day for 6 months, at a single institute. We evaluated changes in endometriosisassociated pain and endometrioma size, and adverse events following dienogest administration, VAS scoring also done. Results- Pain was significantly reduced at 6 months after dienogest medication. The most common adverse drug reaction was headache [42%] followed by 28% nausea and vomiting, associated with high discontinuation rates. A good satisfaction score found, so dienogest might be an effective therapeutic option for the long-term management of Endometriosis. Conclusion- Finally, our study concluded that, Dienogest seems to be effective for the treatment of pain and bleeding abnormalities, associated with endometriosis. Dianogest is a safe, effective. Mean VAS significantly reduced after dianogest use.

Description

.